Cart
sales@molnova.com
Fibrinogen-Binding Peptide
CAS No. 137235-80-4
Fibrinogen-Binding Peptide ( )
Catalog No. M30434 CAS No. 137235-80-4
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameFibrinogen-Binding Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionFibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
-
DescriptionFibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number137235-80-4
-
Formula Weight565.6
-
Molecular FormulaC25H39N7O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Gartner TK, et al. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin. Proc Soc Exp Biol Med. 1991 Oct;198(1):649-55.
molnova catalog
related products
-
20(R)-Notoginsenosid...
20(R)-Notoginsenoside R2 is a natural product with Promote blood circulation and improve myocardial ischemia.
-
Clindamycin
Clindamycin inhibits protein synthesis by acting on the 50S ribosomal.
-
Amifostine
Amifostine is a cytoprotective adjuvant used in Y chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
